A non-invasive prenatal test (NIPT) analyses the DNA circulating in the pregnant mother’s blood from 10 weeks gestation.
It is a new option in prenatal screening for Down syndrome (trisomy 21), Edwards syndrome (trisomy 18 ), Patau’s Syndrome (trisomy 13) and also common chromosomal conditions associated with X and Y chromosome .
This NIPT test can be requested for any singleton or twin pregnancies, including in vitro fertilization (IVF) pregnancies with egg donors.
However, in the twin pregnancies the chromosomal conditions associated with X and Y chromosomes cannot be screened. The NIPT Test is now the most accurate non invasive screening for the most common aneuploidies.